Top Hospitals & Specialists
in Mainland China

China's most prestigious academic medical centre. Benchmark for rare cancers, complex endocrine tumours, and cases requiring multi-disciplinary consensus. Long queues — HelixBridge prioritisation essential.

China's national cancer reference centre. Handles >100,000 new cancer patients per year. Particularly strong in lung, GI, and head & neck cancers. National clinical trial access.

China's highest-volume cardiac surgery centre. Performs more open-heart surgeries per year than any hospital in Asia. Valve repair, LVAD implantation, and complex congenital cases are a particular strength.

Ranked Asia's #1 neurology and neurosurgery centre. Specialises in brain tumours, cerebrovascular malformations, and epilepsy surgery. Global leader in minimally invasive cranial procedures.

China's largest and most influential children's hospital. National leader in paediatric cancer, congenital heart disease, and rare metabolic disorders. Part of the BCH Alliance — 30 affiliated hospitals.

Shanghai's leading cancer specialist hospital. Internationally recognised for breast cancer surgery and precision medicine. Offers molecular tumour boards for complex genomic cases.

China's most cited hospital for clinical research. JCI-accredited. Exceptional for minimally invasive cardiac surgery, TAVI procedures, and liver transplant candidacy evaluation.

Premier destination for neurological second opinions. Best-in-class infectious disease unit (relevant for overseas patients with complex presentations). Strong remote consultation programme.

Strong orthopaedic reconstruction and joint replacement programme. Also a national reference centre for haematological malignancies — unusual combination that suits complex oncology-ortho cases.

One of China's highest-volume IVF centres with documented live-birth rate data. Accepts international patients for full ART cycles including PGT. Well-structured intake for overseas cases.

World's leading centre for nasopharyngeal carcinoma — handles more cases than anywhere globally. Excellent access point for patients from Southeast Asia and Hong Kong. Active phase III trial programme.

South China's most influential cardiology programme. Strong in interventional cardiac procedures and genetic cardiac conditions. Hosts a major genomics research programme relevant for hereditary cardiomyopathies.

Purpose-built women and children's centre in South China. A frequent destination for Hong Kong and overseas families seeking prenatal care or neonatal intensive intervention with Cantonese/English capacity.

The southern satellite of China's premier cardiac centre, purpose-built for cross-border patients from Hong Kong. Faster scheduling than the Beijing flagship. Structural heart disease is a standout programme.

JCI-accredited Shenzhen campus of Peking University Health System. Strategic location for HK patients who want Mainland expertise with minimal travel. Active remote second-opinion platform.

One of Central China's most comprehensive academic medical centres. Particularly strong in oncology and nephrology. Good option for patients in central/western provinces needing a referral hub.

China's most decorated orthopaedic programme. Official sports medicine centre for the Chinese Olympic committee. Spine surgery and arthroplasty volumes are among the highest in Asia.

Leading reproductive medicine unit within a full-service Grade 3A hospital. Strong for complex cases requiring integration between reproductive and general medicine (e.g., autoimmune-related infertility).

A strong neurosurgical programme in the Jiao Tong system. Particularly notable for glioma management using intraoperative awake craniotomy techniques. Also a key gastroenterology centre in East China.

China's premier neurology second-opinion destination, particularly for neurodegenerative disease (Parkinson's, Alzheimer's). Running one of the most active clinical trial programmes for CNS disease in Asia.

Consistently ranked among China's top 3 hospitals overall. Best hospital in western China by significant margin. Enormous surgical volume — particularly strong in hepatobiliary and thoracic oncology.

Globally recognised for limb reconstruction and replantation. Pioneered several techniques now standard practice internationally. A mandatory referral for complex limb trauma, non-unions, and congenital limb difference.

South China's premier IVF programme. High throughput, documented outcomes data, and Cantonese-speaking faculty — preferred choice for Hong Kong couples seeking Mainland ART access.

Strong neurosurgical programme in South China, plus a nationally leading haematology department. Particularly relevant for patients with brain tumours complicated by haematological conditions.

East China's major referral hub outside Shanghai. Particularly strong for haematological second opinions and kidney transplant evaluation. Shorter wait times than Shanghai's top centres for routine complex cases.